Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research사는 이와 같이 세계의 생체흡수성 혈관 스캐폴드 시장에 관한 종합적인 보고서를 발표했습니다. 시장 구조에 대한 자세한 인사이트를 제공합니다.
주요 인사이트
- 생체흡수성 혈관 스캐폴드 시장 규모(2025년) : 3억 1,440만 달러
- 예측 시장 가치(2032년) : 5억 9,280만 달러
- 세계의 시장 성장률(CAGR 2025-2032년) : 8.3%
생체흡수성 혈관 스캐폴드 시장 - 조사 범위 :
생체흡수성 혈관 스캐폴드(BVS)는 체내에서 서서히 용해하면서 혈관에 일시적인 기계적 지지를 주는 것으로 관상동맥 질환의 치료에 사용되는 선진 의료기기입니다. BVS는 후기 스텐트 혈전증과 같은 영구 임플란트와 관련된 장기 합병증을 배제합니다. 그리고 미래에 수술 옵션을 필요로하는 환자에게 점점 더 선호되고 있습니다. 병원, 전문 심장혈관 센터, 외래 수술 유닛에 대응하고 있습니다.
시장 성장 촉진요인 :
세계의 생체흡수성 혈관 스캐폴드 시장은 특히 고령화와 고위험 집단에서 관동맥 질환의 유병률 상승 등 몇 가지 중요한 요인에 의해 추진되고 있습니다. 약물 용출 특성의 향상, 분해 속도의 고속화 등의 기술적 진보는 임상 결과를 향상시켜, 제품 혁신을 촉진하고 있습니다. 또한, 주요 시장에 있어서의 규제 당국의 양호한 승인이나 심혈관 연구에 대한 투자 증가가 시장의 성장을 지지하고 있습니다.신흥국에서도, 헬스 케어 인프라의 정비와 선진
시장 성장 억제요인 :
강력한 성장 가능성에도 불구하고 생체흡수성 혈관 스캐폴드 시장은 높은 장치 비용, 제한된 상환 정책, 비계의 강도 및 장기적인 효과에 대한 우려와 관련된 문제에 직면하고 있습니다. 초기 임상시험에서는 비계의 혈전증에 대한 안전 문제가 제기되었으며 초기 채용에 영향을 미쳤습니다. 참가 기업에 대한 시장 진입의 과제에 박차를 가하고 있습니다. 또한, BVS 이식 기술에 관련하는 급준한 학습 곡선에 기인하는 의사의 주저는 특히 미개발 지역에 있어서 시장 확대를 제한할 가능성이 있습니다.
시장 기회 :
생체흡수성 혈관 스캐폴드 시장은 재료 과학, 생분해성 약물전달 시스템 및 정밀 기반 심혈관 인터벤션에서 기술 혁신에 견인되는 큰 기회를 제시하고 있습니다. 최적화된 성능과 더 빠른 흡수 속도를 가진 차세대 스캐폴드 개발에 박차를 가하고 있습니다. 수술 감소의 가능성으로 인해 BVS는 장기적으로 비용 효율적인 솔루션으로 자리매김하고 있습니다.
이 보고서에서 다루는 주요 질문
- 세계의 생체흡수성 혈관 스캐폴드 시장 성장을 가속하는 주요 요인은?
- BVS 분야의 기술 혁신을 리드하고 있는 것은 어느 재료와 기술인가?
- 임상 결과와 환자의 안전성은 헬스케어 시스템 전체에 있어서의 BVS의 채용에 어떠한 영향을 주고 있는가
- 생체흡수성 혈관 스캐폴드 시장에 공헌하고 있는 주요 기업은 누구로 성장을 유지하기 위해 어떤 전략적 움직임을 보이고 있는가?
- 세계 생체흡수성 혈관 스캐폴드 시장의 새로운 동향과 장기적 전망은?
목차
제1장 주요 요약
제2장 시장 개요
- 시장의 범위와 정의
- 시장 역학
- 거시경제 요인
- 생분해성 폴리머와 차세대 스캐폴드 설계의 개발
- 생체 적합성이 향상되어 분해 속도가 제어된 신규 폴리머의 엔지니어링
- COVID-19의 영향 분석
- 예측 요인 - 관련성과 영향
제3장 부가가치가 있는 인사이트
- 툴 채용 분석
- 규제 상황
- 밸류체인 분석
- PESTLE 분석
- Porter's Five Forces 분석
제4장 가격 분석(2025년)
- 주요 하이라이트
- 도입 비용에 영향을 미치는 주요 요인
- 기업 유형별 가격 분석
제5장 세계의 생체흡수성 혈관 스캐폴드 시장 전망
- 주요 하이라이트
- 시장 규모 예측
- 시장 규모와 전년대비 성장률
- 절대 수익 기회
- 시장 규모와 수량 분석 및 예측
- 과거 시장 규모(백만 달러) 분석(2019-2024년)
- 시장 규모(백만 달러)의 분석과 예측(2025-2032년)
- 세계의 생체흡수성 혈관 스캐폴드 시장 전망 : 제품
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석(2019-2024년)
- 시장 규모(백만 달러)와 수량(유닛)의 분석과 예측(2025-2032년)
- 금속 생체흡수성 혈관 스캐폴드
- 폴리머 생체흡수성 혈관 스캐폴드
- 시장 매력 분석 : 제품
- 세계의 생체흡수성 혈관 스캐폴드 시장 전망 : 용도
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러) 분석(2019-2024년)
- 시장 규모(백만 달러)의 분석과 예측(2025-2032년)
- 시장 매력 분석 : 응용
- 세계의 생체흡수성 혈관 스캐폴드 시장 전망 : 최종 사용자
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러) 분석(2019-2024년)
- 시장 규모(백만 달러)의 분석과 예측(2025-2032년)
- 병원
- 외래수술센터(ASC)
- 심장 카테터 검사실
- 기타
- 시장 매력 분석 : 최종 사용자
제6장 세계의 생체흡수성 혈관 스캐폴드 시장 전망 : 지역
- 주요 하이라이트
- 과거 시장 규모와 수량의 추이 분석(2019-2024년)
- 시장 규모와 수량의 분석과 예측(2025-2032년)
- 북미
- 유럽
- 동아시아
- 남아시아와 오세아니아
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력 분석 : 지역
제7장 북미의 생체흡수성 혈관 스캐폴드 시장 전망
제8장 유럽의 생체흡수성 혈관 스캐폴드 시장 전망
제9장 동아시아의 생체흡수성 혈관 스캐폴드 시장 전망
제10장 남아시아 및 오세아니아의 생체흡수성 혈관 스캐폴드 시장 전망
제11장 라틴아메리카의 생체흡수성 혈관 스캐폴드 시장 전망
제12장 중동 및 아프리카의 생체흡수성 혈관 스캐폴드 시장 전망
제13장 경쟁 구도
- 시장 점유율 분석(2025년)
- 시장 구조
- 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
- Meril Life Sciences Pvt. Ltd.
- Zeus Company LLC
- Biotronik
- Abbott
- MicroPort Scientific Corporation
- Kyoto Medical
- Elixir Medical
- Cigna
- B. Braun Melsungen AG
- Boston Scientific Corporation
- REVA Medical
제14장 부록
KTH
Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bioresorbable vascular scaffold market from 2025 to 2032.
Key Insights:
- Bioresorbable Vascular Scaffold Market Size (2025E): USD 314.4 Million
- Projected Market Value (2032F): USD 592.8 Million
- Global Market Growth Rate (CAGR 2025 to 2032): 8.3%
Bioresorbable Vascular Scaffold Market - Report Scope:
Bioresorbable vascular scaffolds (BVS) are advanced medical devices used to treat coronary artery disease by providing temporary mechanical support to blood vessels while gradually dissolving in the body. Unlike traditional metallic stents, BVS eliminate the long-term complications associated with permanent implants, such as late stent thrombosis. These scaffolds are primarily utilized in percutaneous coronary intervention (PCI) procedures and are increasingly preferred for younger patients or those requiring future surgical options. The BVS market caters to hospitals, specialty cardiovascular centers, and ambulatory surgical units, offering innovative scaffolds made from polylactic acid (PLA), polycarbonate, and other bioresorbable polymers. Market expansion is driven by a growing burden of cardiovascular diseases, increased demand for next-generation stent technologies, and a shift toward minimally invasive treatment options.
Market Growth Drivers:
The global bioresorbable vascular scaffold market is propelled by several key factors, including the rising prevalence of coronary artery disease, especially in aging and high-risk populations. Increasing patient and physician preference for temporary implants that minimize long-term complications has accelerated the adoption of BVS over traditional stents. Technological advancements, including improved scaffold designs, enhanced drug-eluting properties, and faster degradation rates, are enhancing clinical outcomes and driving product innovation. Furthermore, favorable regulatory approvals in major markets and growing investment in cardiovascular research are supporting market growth. Emerging economies are also witnessing increased adoption due to the rise in healthcare infrastructure and awareness of advanced cardiovascular therapies.
Market Restraints:
Despite its strong growth potential, the bioresorbable vascular scaffold market faces challenges related to high device costs, limited reimbursement policies, and concerns about scaffold strength and long-term efficacy. Initial clinical trials raised safety issues regarding scaffold thrombosis, which impacted early adoption. Regulatory hurdles, including stringent safety evaluations and complex approval pathways, add to market entry challenges for new players. Additionally, physician hesitancy due to the steep learning curve associated with BVS implantation techniques can restrict market expansion, particularly in underdeveloped regions. Addressing these issues through improved training, transparent clinical data, and cost-effective solutions remains essential for broader acceptance.
Market Opportunities:
The bioresorbable vascular scaffold market presents significant opportunities driven by innovations in material science, biodegradable drug delivery systems, and precision-based cardiovascular interventions. The increasing use of advanced imaging and diagnostic tools to support accurate scaffold placement enhances procedural success and patient outcomes. Collaborations between medical device manufacturers and academic institutions are fueling the development of next-generation scaffolds with optimized performance and faster resorption rates. As healthcare systems shift toward value-based care, the potential for reduced long-term complications and repeat procedures positions BVS as a cost-effective solution over time. Expansion into emerging markets and the rising trend of outpatient PCI procedures offer further growth avenues.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
- Which materials and technologies are leading innovation in the BVS sector?
- How are clinical outcomes and patient safety influencing the adoption of BVS across healthcare systems?
- Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategic moves are they making to sustain growth?
- What are the emerging trends and long-term prospects in the global BVS market?
Competitive Intelligence and Business Strategy:
These companies invest significantly in R&D to enhance scaffold performance, reduce resorption time, and improve patient outcomes. Strategic partnerships with hospitals, research organizations, and cardiovascular societies facilitate clinical adoption and expand global reach. Additionally, market participants are prioritizing physician education programs, post-marketing surveillance studies, and expansion into high-growth regions to strengthen their market position and drive the transition toward bioresorbable technologies in cardiovascular care.
Key Companies Profiled:
- Meril Life Sciences Pvt. Ltd.
- Zeus Company LLC
- Biotronik
- Abbott
- MicroPort Scientific Corporation
- Kyoto Medical
- Elixir Medical (MedImpact Healthcare Systems, Inc.)
- Cigna
- B. Braun Melsungen AG
- Boston Scientific Corporation
- REVA Medical
Bioresorbable Vascular Scaffold Market Research Segmentation:
The bioresorbable vascular scaffold market encompasses a variety of materials, technologies, applications, and end-user segments tailored to the evolving needs of cardiovascular intervention.
By Product
- Metal Bioresorbable Vascular Scaffold
- Polymer Bioresorbable Vascular Scaffold
By Application
- Peripheral Artery
- Coronary Artery
By End-user
- Hospitals
- Ambulatory Care Centers
- Cardiac Centers
- Others
By Region
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-economic Factors
- 2.3.1. The development of biodegradable polymers and next-gen scaffold designs
- 2.3.2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Tool Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. PESTLE Analysis
- 3.5. Porter's Five Force Analysis
4. Price Analysis, 2025A
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Deployment Costs
- 4.3. Pricing Analysis, By Enterprise Type
5. Global Bioresorbable Vascular Scaffold Market Outlook
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
- 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 5.3.3.1. Metal Bioresorbable Vascular Scaffold
- 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
- 5.3.4. Market Attractiveness Analysis: Product
- 5.4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
- 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 5.4.3.1. Peripheral Artery
- 5.4.3.2. Coronary Artery
- 5.4.4. Market Attractiveness Analysis: Application
- 5.5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
- 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 5.5.3.1. Hospitals
- 5.5.3.2. Ambulatory Surgical Centers
- 5.5.3.3. Cardiac Catheterization Labs
- 5.5.3.4. Others
- 5.5.4. Market Attractiveness Analysis: End-user
6. Global Bioresorbable Vascular Scaffold Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
- 6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
7. North America Bioresorbable Vascular Scaffold Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Application
- 7.2.4. By End-user
- 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 7.4.1.
- 7.4.1.1. Metal Bioresorbable Vascular Scaffold
- 7.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Peripheral Artery
- 7.5.2. Coronary Artery
- 7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Surgical Centers
- 7.6.3. Cardiac Catheterization Labs
- 7.6.4. Others
- 7.7. Market Attractiveness Analysis
8. Europe Bioresorbable Vascular Scaffold Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Application
- 8.2.4. By End-user
- 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 8.4.1.
- 8.4.1.1. Metal Bioresorbable Vascular Scaffold
- 8.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 8.5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025-2032
- 8.5.1. Peripheral Artery
- 8.5.2. Coronary Artery
- 8.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Surgical Centers
- 8.6.3. Cardiac Catheterization Labs
- 8.6.4. Others
- 8.7. Market Attractiveness Analysis
9. East Asia Bioresorbable Vascular Scaffold Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By End-user
- 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 9.4.1.
- 9.4.1.1. Metal Bioresorbable Vascular Scaffold
- 9.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Peripheral Artery
- 9.5.2. Coronary Artery
- 9.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers
- 9.6.3. Cardiac Catheterization Labs
- 9.6.4. Others
- 9.7. Market Attractiveness Analysis
10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By End-user
- 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 10.4.1.
- 10.4.1.1. Metal Bioresorbable Vascular Scaffold
- 10.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Peripheral Artery
- 10.5.2. Coronary Artery
- 10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Surgical Centers
- 10.6.3. Cardiac Catheterization Labs
- 10.6.4. Others
- 10.7. Market Attractiveness Analysis
11. Latin America Bioresorbable Vascular Scaffold Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By End-user
- 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 11.4.1.
- 11.4.1.1. Metal Bioresorbable Vascular Scaffold
- 11.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Peripheral Artery
- 11.5.2. Coronary Artery
- 11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers
- 11.6.3. Cardiac Catheterization Labs
- 11.6.4. Others
- 11.7. Market Attractiveness Analysis
12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By End-user
- 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 12.4.1.
- 12.4.1.1. Metal Bioresorbable Vascular Scaffold
- 12.4.1.2. Polymer Bioresorbable Vascular Scaffold
- 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 12.5.1. Peripheral Artery
- 12.5.2. Coronary Artery
- 12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Surgical Centers
- 12.6.3. Cardiac Catheterization Labs
- 12.6.4. Others
- 12.7. Market Attractiveness Analysis
13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Meril Life Sciences Pvt. Ltd.
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Deployments
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Zeus Company LLC
- 13.3.3. Biotronik
- 13.3.4. Abbott
- 13.3.5. MicroPort Scientific Corporation
- 13.3.6. Kyoto Medical
- 13.3.7. Elixir Medical
- 13.3.8. Cigna
- 13.3.9. B. Braun Melsungen AG
- 13.3.10. Boston Scientific Corporation
- 13.3.11. REVA Medical
14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
